12-week Open-label Evaluation of Efficacy and Safety of Indacaterol
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
In this 12-week study, patients were randomized to either open-label indacaterol or standard
of care for Chronic Obstructive Pulmonary Disease (COPD) treatment; efficacy and safety were
assessed.